{"id":401462,"date":"2020-12-16T20:24:10","date_gmt":"2020-12-17T01:24:10","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=401462"},"modified":"2020-12-16T20:24:10","modified_gmt":"2020-12-17T01:24:10","slug":"prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/","title":{"rendered":"PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. &#8211; PRVL"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">NEW ORLEANS<\/span>, <span class=\"xn-chron\">Dec. 16, 2020<\/span> \/PRNewswire\/ &#8212;\u00a0Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick &amp; Foti, LLC (&#8220;KSF&#8221;) are investigating the proposed sale of Prevail Therapeutics Inc. (NasdaqGS: PRVL) to Eli Lilly and Company (NYSE: LLY). \u00a0Under the terms of the proposed transaction, shareholders of Prevail will receive only <span class=\"xn-money\">$22.50<\/span> in cash plus one non-tradable contingent value right worth up to <span class=\"xn-money\">$4.00<\/span> per share in cash (subject to certain terms and conditions) for each share of Prevail that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg\" title=\"Kahn Swick &amp; Foti, LLC (&quot;KSF&quot;) - - not all law firms are created equal.  Visit www.ksfcounsel.com to learn more about KSF. (PRNewsfoto\/Kahn Swick &amp; Foti, LLC)\" alt=\"Kahn Swick &amp; Foti, LLC (&quot;KSF&quot;) - - not all law firms are created equal.  Visit www.ksfcounsel.com to learn more about KSF. (PRNewsfoto\/Kahn Swick &amp; Foti, LLC)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>If you believe that this transaction undervalues the Company and\/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (<a href=\"mailto:lewis.kahn@ksfcounsel.com\" rel=\"nofollow\">lewis.kahn@ksfcounsel.com<\/a>) toll free at any time at 855-768-1857, or visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3015949-1&amp;h=579664193&amp;u=https%3A%2F%2Fwww.ksfcounsel.com%2Fcases%2Fnasdaqgs-prvl%2F&amp;a=https%3A%2F%2Fwww.ksfcounsel.com%2Fcases%2Fnasdaqgs-prvl%2F\" rel=\"nofollow noopener noreferrer\">https:\/\/www.ksfcounsel.com\/cases\/nasdaqgs-prvl\/<\/a> to learn more.<\/p>\n<p>\n        <b><br \/>\n          <i>Please note that the merger is structured as a tender offer, such that time may be of the essence.<\/i><br \/>\n        <\/b>\n      <\/p>\n<p>To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3015949-1&amp;h=2216678441&amp;u=http%3A%2F%2Fwww.ksfcounsel.com%2F&amp;a=www.ksfcounsel.com\" rel=\"nofollow noopener noreferrer\">www.ksfcounsel.com<\/a>.<\/p>\n<p>Kahn Swick &amp; Foti, LLC<br \/>1100 Poydras St., Suite 3200<br \/><span class=\"xn-location\">New Orleans, LA<\/span> 70163<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=DA27021&amp;sd=2020-12-16\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick--foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc---prvl-301194658.html\">http:\/\/www.prnewswire.com\/news-releases\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick&#8211;foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc&#8212;prvl-301194658.html<\/a><\/p>\n<p>SOURCE  Kahn Swick &amp; Foti, LLC<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DA27021&amp;Transmission_Id=202012162021PR_NEWS_USPR_____DA27021&amp;DateId=20201216\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW ORLEANS, Dec. 16, 2020 \/PRNewswire\/ &#8212;\u00a0Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick &amp; Foti, LLC (&#8220;KSF&#8221;) are investigating the proposed sale of Prevail Therapeutics Inc. (NasdaqGS: PRVL) to Eli Lilly and Company (NYSE: LLY). \u00a0Under the terms of the proposed transaction, shareholders of Prevail will receive only $22.50 in cash plus one non-tradable contingent value right worth up to $4.00 per share in cash (subject to certain terms and conditions) for each share of Prevail that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. &#8211; PRVL&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-401462","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. - PRVL - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. - PRVL - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW ORLEANS, Dec. 16, 2020 \/PRNewswire\/ &#8212;\u00a0Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick &amp; Foti, LLC (&#8220;KSF&#8221;) are investigating the proposed sale of Prevail Therapeutics Inc. (NasdaqGS: PRVL) to Eli Lilly and Company (NYSE: LLY). \u00a0Under the terms of the proposed transaction, shareholders of Prevail will receive only $22.50 in cash plus one non-tradable contingent value right worth up to $4.00 per share in cash (subject to certain terms and conditions) for each share of Prevail that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this &hellip; Continue reading &quot;PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. &#8211; PRVL&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-17T01:24:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. &#8211; PRVL\",\"datePublished\":\"2020-12-17T01:24:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\\\/\"},\"wordCount\":273,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/399590\\\/Kahn_Swick_and_Foti_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\\\/\",\"name\":\"PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. - PRVL - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/399590\\\/Kahn_Swick_and_Foti_Logo.jpg\",\"datePublished\":\"2020-12-17T01:24:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/399590\\\/Kahn_Swick_and_Foti_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/399590\\\/Kahn_Swick_and_Foti_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. &#8211; PRVL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. - PRVL - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/","og_locale":"en_US","og_type":"article","og_title":"PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. - PRVL - Market Newsdesk","og_description":"PR Newswire NEW ORLEANS, Dec. 16, 2020 \/PRNewswire\/ &#8212;\u00a0Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick &amp; Foti, LLC (&#8220;KSF&#8221;) are investigating the proposed sale of Prevail Therapeutics Inc. (NasdaqGS: PRVL) to Eli Lilly and Company (NYSE: LLY). \u00a0Under the terms of the proposed transaction, shareholders of Prevail will receive only $22.50 in cash plus one non-tradable contingent value right worth up to $4.00 per share in cash (subject to certain terms and conditions) for each share of Prevail that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this &hellip; Continue reading \"PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. &#8211; PRVL\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-17T01:24:10+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. &#8211; PRVL","datePublished":"2020-12-17T01:24:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/"},"wordCount":273,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/","name":"PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. - PRVL - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg","datePublished":"2020-12-17T01:24:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/399590\/Kahn_Swick_and_Foti_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prevail-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-prevail-therapeutics-inc-p\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PREVAIL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prevail Therapeutics Inc. &#8211; PRVL"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=401462"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401462\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=401462"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=401462"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=401462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}